DE LUCA, Annamaria

DE LUCA, Annamaria  

DIPARTIMENTO DI FARMACIA-SCIENZE DEL FARMACO  

Mostra records
Risultati 1 - 20 di 283 (tempo di esecuzione: 0.021 secondi).
Titolo Data di pubblicazione Autore(i) File
"Of Mice and Measures": A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic 1-gen-2018 Gordish-Dressman, H; Willmann, R; Pazze, Ld; Kreibich, A; van Putten, M; Heydemann, A; Bogdanik, L; Lutz, C; Davies, K; Demonbruen, Ar; Duan, D; Elsey, D; Fukada, Si; Girgenrath, M; Gonzalez, Jp; Grounds, Md; Nichols, A; Partridge, T; Passini, M; Sanarica, F; Schnell, Fj; Wells, Dj; Yokota, T; Young, Cs; Zhong, Z; Spurney, C; Spencer, M; De Luca, A; Nagaraju, K; Aartsma-Rus, A.
"The Social Network" and Muscular Dystrophies: The Lesson Learnt about the Niche Environment as a Target for Therapeutic Strategies 1-gen-2020 Cappellari, O.; Mantuano, P.; De Luca, A.
(2) Save to: more options Isosteric derivates of mexiletine: New potent use-dependent blockers of skeletal muscle sodium channels with potential antimyotonic activity 1-gen-2001 Talon, S; DE LUCA, Annamaria; De Bellis, M; Franchini, C; Lentini, Giovanni; Tortorella, V; Camerino, Dc
227thENMC International Workshop:. Finalizing a plan to guarantee quality in translational research for neuromuscular diseases Heemskerk, Netherlands, 10-11 February 2017 1-gen-2018 Willmann, Raffaella; Buccella, Filippo; De Luca, Annamaria; Grounds, Miranda D.; Versnel, J.; Vroom, E.; Ribeiro, D.; Ambrosini, A; Pavlath, G.; Porter, J.; Dziewczapolski, G; Dubowitz, V.; Lochmüller, H; Campbell, K.; Davies, K.; Roth, K. A.; Clark, A.; Clementi, E.; Nagaraju, K.; Goemans, N.; Straub, V.; Klein, A.; van Putten, M.; Fries, M.; Sheean, M.; Tinsley, J.; Girgenrath, M.
A decade of optimizing drug development for rare neuromuscular disorders through TACT 1-gen-2020 Wagner, K. R.; De Luca, A.; Caizergues, D.; Dowling, J.; Goemans, N.; Gordish-Dressman, H.; Grounds, M. D.; Kelly, M.; Mayhew, A.; Mcnally, E. M.; Zoetis, T.; Lee, J.; Turner, C.; Wells, D. J.; Csimma, C.; Straub, V.
A long-term treatment with taurine prevents cardiac dysfunction in mdx mice 1-gen-2019 Mele, Antonietta; Mantuano, Paola; DE BELLIS, Michela; Rana, Francesco; Sanarica, Francesca; Conte, Elena; Morgese Maria, Grazia; Bove, Maria; Rolland, Jeanfrancois; Capogrosso, Roberta Francesca; Pierno, Sabata; Camerino, GIULIA MARIA; Trabace, Luigia; De Luca, Annamaria.
A multidisciplinary evaluation of the effectiveness of cyclosporine A in dystrophic mdx mice 1-gen-2005 DE LUCA, A.; Nico, B.; Liantonio, A.; Didonna, M. P.; Fraysse, B.; Pierno, S.; Burdi, R.; Mangieri, D.; Rolland, J. F.; Camerino, C.; Zallone, A.; Confalonieri, P.; Andreetta, F.; Arnoldi, E.; CORDIER-FRUH, I.; Magyar, J. P.; Frigeri, A.; Pisoni, Michela; Svelto, M.; Conte, D
A new benzylated proline-like tocainide derivative is a potent use dependent skeletal muscle Na+ channel blocker with a potential antimyotonic activity 1-gen-2001 Talon, S.; DE LUCA, A.; DE BELLIS, Michela; Desaphy, J. F.; Lentini, Giovanni; Scilimati, Antonio; Corbo, Filomena Faustina Rina; Franchini, C.; Tortorella, V.; CONTE CAMERINO, D.
A new benzylated proline-like tocainide derivative is a potent use-dependent skeletal muscle Na+ channel blocker with a potential anti-myotonic activity 1-gen-2001 Talon, S.; DE LUCA, Annamaria; DE BELLIS, Michela; Desaphy, Jean Francois; Lentini, Giovanni; Scilimati, Antonio; Corbo, F.; Franchini, Carlo; Tortorella, V.; Conte Camerino, D.
A new original compound, which inhibits calpain 1-2 and reactive oxygen species, reduces the dystrophic progression of mdx mice 1-gen-2005 Pignol, B; Burdi, R; Didonna, M; Rolland, Jf; Ferro, P; Confalonieri, P; Cooperd, R; Butler Browne, G; DE LUCA, Annamaria
A novel kcna2 variant in a patient with non-progressive congenital ataxia and epilepsy: Functional characterization and sensitivity to 4-aminopyridine 1-gen-2021 Imbrici, P.; Conte, E.; Blunck, R.; Stregapede, F.; Liantonio, A.; Tosi, M.; D'Adamo, M. C.; De Luca, A.; Brankovic, V.; Zanni, G.
A stereospecific binding site regulates the C1- ion channel in rat skeletal muscle 1-gen-1988 Conte, Diana; Tortorella, V; Bettoni, G; Bryant S., H; DE LUCA, Annamaria; Mambrini, M; Tricarico D., Grasso
A stereospecific bindings site regulates the Cl- ion channel in rat skeletal muscle 1-gen-1988 Conte, Diana; Tortorella, V; Bettoni, G; Bryant, Sh; DE LUCA, Annamaria; Mambrini, M; Tricarico, Domenico; Grasso, G.
Aberrant mechanical-metabolic coupling in muscular dystrophy: gene expression and functional studies in mdx mouse muscle in relation to age and exercise 1-gen-2014 Camerino, GIULIA MARIA; Capogrosso, R; Cannone, M; Mantuano, P; Giustino, Arcangela; Massari, A; DE LUCA, Annamaria; Grange, R; De Luca, A.
Age-dependent modification of phosphorylation state of skeletal muscle chloride channel controls its biophysical and pharmacological properties 1-gen-1996 DE LUCA, Annamaria; Pierno, S; Tortorella, V; Conte Camerino, D.
Aging and chloride channel regulation in rat fast-twitch muscle fibres 1-gen-1994 DE LUCA, Annamaria; Tricarico, Domenico; Pierno, Sabata; Conte, Diana
Aging-associated down-regulation of CLC-1 expression in skeletal muscle: phenotypic-independent relation to the decrease of chloride conductance 1-gen-1999 Pierno, Sabata; DE LUCA, Annamaria; Beck, C. L.; George, A. L.; Conte, Diana
Alteration of endothelium dependent vascular relaxation by aging and effect of a growth hormone-releasing peptide 1-gen-1997 Lograno M., D; Daniele, E; DE LUCA, Annamaria; Conte Camerino, D.
Alteration of excitation-contraction coupling mechanism in extensor digitorum longus muscle fibres of dystrophic mdx mouse and potential efficacy of taurine 1-gen-2001 DE LUCA, Annamaria; Pierno, Sabata; Liantonio, Antonella; Cetrone, M.; Camerino, C.; Simonetti, S.; Papadia, F.; Conte, Diana
Alteration of stim1/orai1-mediated soce in skeletal muscle: Impact in genetic muscle diseases and beyond 1-gen-2021 Conte, E.; Imbrici, P.; Mantuano, P.; Coppola, M. A.; Camerino, G. M.; De Luca, A.; Liantonio, A.